Literature DB >> 29566449

Quantitative susceptibility mapping (QSM) minimizes interference from cellular pathology in R2* estimation of liver iron concentration.

Jianqi Li1, Huimin Lin2, Tian Liu3, Zhuwei Zhang4, Martin R Prince3, Kelly Gillen3, Xu Yan5, Qi Song2, Ting Hua4, Xiance Zhao1, Miao Zhang1, Yu Zhao1, Gaiying Li1, Guangyu Tang4, Guang Yang1, Gary M Brittenham6, Yi Wang1,3,7.   

Abstract

BACKGROUND: A challenge for R2 and R2* methods in measuring liver iron concentration (LIC) is that fibrosis, fat, and other hepatic cellular pathology contribute to R2 and R2* and interfere with LIC estimation.
PURPOSE: To examine the interfering effects of fibrosis, fat, and other lesions on R2* LIC estimation and to use quantitative susceptibility mapping (QSM) to reduce these distortions. STUDY TYPE: Prospective. PHANTOMS,
SUBJECTS: Water phantoms with various concentrations of gadolinium (Gd), collagen (Cl, modeling fibrosis), and fat; nine healthy controls with no known hepatic disease, nine patients with known or suspected hepatic iron overload, and nine patients with focal liver lesions. FIELD STRENGTH/SEQUENCE: The phantoms and human subjects were imaged using a 3D multiecho gradient-echo on clinical 1.5T and 3T MRI systems. ASSESSMENT: QSM and R2* images were postprocessed from the same gradient-echo data. Fat contributions to susceptibility and R2* were corrected in signal models for LIC estimation. STATISTICAL TESTS: Polynomial regression analyses were performed to examine relations among susceptibility, R2* and true [Gd] and [Cl] in phantoms, and among susceptibility and R2* in patient livers.
RESULTS: In phantoms, R2* had a strong nonlinear dependency on [Cl], [fat], and [Gd], while susceptibility was linearly dependent (R2  > 0.98). In patients, R2* was highly sensitive to liver pathological changes, including fat, fibrosis, and tumors, while QSM was relatively insensitive to these abnormalities (P = 0.015). With moderate iron overload, liver susceptibility and R2* were not linearly correlated over a common R2* range [0, 100] sec-1 (P = 0.35). DATA
CONCLUSION: R2* estimation of LIC is prone to substantial nonlinear interference from fat, fibrosis, and other lesions. QSM processing of the same gradient echo MRI data can effectively minimize the effects of cellular pathology. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2018;48:1069-1079.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  QSM; cellularity; liver iron concentration; magnetic susceptibility; quantitative susceptibility mapping

Mesh:

Substances:

Year:  2018        PMID: 29566449      PMCID: PMC6151179          DOI: 10.1002/jmri.26019

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  39 in total

Review 1.  Evaluation of iron overload.

Authors:  Peter-D Jensen
Journal:  Br J Haematol       Date:  2004-03       Impact factor: 6.998

2.  Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field.

Authors:  Ludovic de Rochefort; Ryan Brown; Martin R Prince; Yi Wang
Journal:  Magn Reson Med       Date:  2008-10       Impact factor: 4.668

3.  Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis.

Authors:  Ellen Butensky; Roland Fischer; Mark Hudes; Laurie Schumacher; Roger Williams; Thomas P Moyer; Elliott Vichinsky; Paul Harmatz
Journal:  Am J Clin Pathol       Date:  2005-01       Impact factor: 2.493

4.  Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors.

Authors:  Kofi Deh; Thanh D Nguyen; Sarah Eskreis-Winkler; Martin R Prince; Pascal Spincemaille; Susan Gauthier; Ilhami Kovanlikaya; Yan Zhang; Yi Wang
Journal:  J Magn Reson Imaging       Date:  2015-05-09       Impact factor: 4.813

Review 5.  Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.

Authors:  Yi Wang; Pascal Spincemaille; Zhe Liu; Alexey Dimov; Kofi Deh; Jianqi Li; Yan Zhang; Yihao Yao; Kelly M Gillen; Alan H Wilman; Ajay Gupta; Apostolos John Tsiouris; Ilhami Kovanlikaya; Gloria Chia-Yi Chiang; Jonathan W Weinsaft; Lawrence Tanenbaum; Weiwei Chen; Wenzhen Zhu; Shixin Chang; Min Lou; Brian H Kopell; Michael G Kaplitt; David Devos; Toshinori Hirai; Xuemei Huang; Yukunori Korogi; Alexander Shtilbans; Geon-Ho Jahng; Daniel Pelletier; Susan A Gauthier; David Pitt; Ashley I Bush; Gary M Brittenham; Martin R Prince
Journal:  J Magn Reson Imaging       Date:  2017-03-10       Impact factor: 4.813

Review 6.  Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis.

Authors:  P Nahon; N Ganne-Carrié; J-C Trinchet; M Beaugrand
Journal:  Gastroenterol Clin Biol       Date:  2009-09-16

7.  T1 independent, T2* corrected MRI with accurate spectral modeling for quantification of fat: validation in a fat-water-SPIO phantom.

Authors:  Catherine D G Hines; Huanzhou Yu; Ann Shimakawa; Charles A McKenzie; Jean H Brittain; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2009-11       Impact factor: 4.813

8.  Quantitative susceptibility mapping in the abdomen as an imaging biomarker of hepatic iron overload.

Authors:  Samir D Sharma; Diego Hernando; Debra E Horng; Scott B Reeder
Journal:  Magn Reson Med       Date:  2014-09-08       Impact factor: 4.668

9.  Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study.

Authors:  Yesim Aydinok; John B Porter; Antonio Piga; Mohsen Elalfy; Amal El-Beshlawy; Yurdanur Kilinç; Vip Viprakasit; Akif Yesilipek; Dany Habr; Erhard Quebe-Fehling; Dudley J Pennell
Journal:  Eur J Haematol       Date:  2015-01-08       Impact factor: 2.997

10.  Comparison of 3 T and 1.5 T for T2* magnetic resonance of tissue iron.

Authors:  Mohammed H Alam; Dominique Auger; Laura-Ann McGill; Gillian C Smith; Taigang He; Cemil Izgi; A John Baksi; Rick Wage; Peter Drivas; David N Firmin; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2016-07-08       Impact factor: 5.364

View more
  21 in total

1.  Rapid automated liver quantitative susceptibility mapping.

Authors:  Ramin Jafari; Sujit Sheth; Pascal Spincemaille; Thanh D Nguyen; Martin R Prince; Yan Wen; Yihao Guo; Kofi Deh; Zhe Liu; Daniel Margolis; Gary M Brittenham; Andrea S Kierans; Yi Wang
Journal:  J Magn Reson Imaging       Date:  2019-01-13       Impact factor: 4.813

2.  Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease.

Authors:  Mustafa R Bashir; Tanya Wolfson; Anthony C Gamst; Kathryn J Fowler; Michael Ohliger; Shetal N Shah; Adina Alazraki; Andrew T Trout; Cynthia Behling; Daniela S Allende; Rohit Loomba; Arun Sanyal; Jeffrey Schwimmer; Joel E Lavine; Wei Shen; James Tonascia; Mark L Van Natta; Adrija Mamidipalli; Jonathan Hooker; Kris V Kowdley; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2018-10-14       Impact factor: 4.813

Review 3.  Topics on quantitative liver magnetic resonance imaging.

Authors:  Yì Xiáng J Wáng; Xiaoqi Wang; Peng Wu; Yajie Wang; Weibo Chen; Huijun Chen; Jianqi Li
Journal:  Quant Imaging Med Surg       Date:  2019-11

4.  Measurement of the liver iron concentration in transfusional iron overload by MRI R2* and by high-transition-temperature superconducting magnetic susceptometry.

Authors:  Sujit Sheth; Christopher J Allen; David E Farrell; John H Tripp; Ramin Jafari; Yi Wang; Gary M Brittenham
Journal:  Clin Imaging       Date:  2019-01-31       Impact factor: 1.605

Review 5.  MR imaging assessment and quantification of liver iron.

Authors:  Manuela França; João Gomes Carvalho
Journal:  Abdom Radiol (NY)       Date:  2020-11

6.  Radiomics nomograms based on R2* mapping and clinical biomarkers for staging of liver fibrosis in patients with chronic hepatitis B: a single-center retrospective study.

Authors:  Die Zhang; Yi Cao; Yi Sun; Xia Zhao; Cheng Peng; Jing Zhao; Xiaohui Bao; Lifei Wang; Chen Zhang
Journal:  Eur Radiol       Date:  2022-09-23       Impact factor: 7.034

7.  Integrated quantitative susceptibility and R2 * mapping for evaluation of liver fibrosis: An ex vivo feasibility study.

Authors:  Ramin Jafari; Stefanie J Hectors; Anne K Koehne de González; Pascal Spincemaille; Martin R Prince; Gary M Brittenham; Yi Wang
Journal:  NMR Biomed       Date:  2020-09-22       Impact factor: 4.044

8.  Quantitative Susceptibility Mapping: MRI at 7T versus 3T.

Authors:  Pascal Spincemaille; Julie Anderson; Gaohong Wu; Baolian Yang; Maggie Fung; Ke Li; Shaojun Li; Ilhami Kovanlikaya; Ajay Gupta; Douglas Kelley; Nissim Benhamo; Yi Wang
Journal:  J Neuroimaging       Date:  2019-10-18       Impact factor: 2.486

9.  Magnetic resonance quantitative susceptibility mapping in the evaluation of hepatic fibrosis in chronic liver disease: a feasibility study.

Authors:  Zheng Qu; Shuohui Yang; Feng Xing; Rui Tong; Chenyao Yang; Rongfang Guo; Jiling Huang; Fang Lu; Caixia Fu; Xu Yan; Stefanie Hectors; Kelly Gillen; Yi Wang; Chenghai Liu; Songhua Zhan; Jianqi Li
Journal:  Quant Imaging Med Surg       Date:  2021-04

10.  Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning.

Authors:  E Louise Thomas; Madeleine Cule; Yi Liu; Nicolas Basty; Brandon Whitcher; Jimmy D Bell; Elena P Sorokin; Nick van Bruggen
Journal:  Elife       Date:  2021-06-15       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.